Brimonidine
Active ingredient · 3 therapeutic classes
Sold as Mirvaso · ONRELTEA
- Drug class
- Other Dermatologicals
- Availability
- See label
- Routes
- Ophthalmic, Topical
- Markets covered
- 3
- Products on record
- 28
Overview
Brimonidine is an active pharmaceutical ingredient in the Other Dermatologicals group (D11AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 21 | May 29, 2026 |
| CA Canada | Health Canada | 6 | October 22, 2025 |
| EU European Union | EMA | 1 | March 4, 2025 |
GBUnited Kingdom· MHRA
21 products
Uses
1).
How to take
CACanada· Health Canada
6 products
Uses
15% (preserved with sodium chlorite) is indicated for • the control of intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. 1 Pediatrics Pediatrics (< 18 years of age): The safety and efficacy of BRIMONIDINE P has not been established in pediatric patients; therefore, Health Canada has not authorized an indication for pediatric use.
2% in pediatric populations. See
How to take
EUEuropean Union· EMA
1 product
Uses
Mirvaso is indicated for the symptomatic treatment of facial erythema of rosacea in adult patients.
How to take
Drug interactions
Known interactions involving Brimonidine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 469. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL311030047 · revised May 1, 2026
- [2]Health Canada (DPD) · 02301334 · revised March 22, 2025
- [3]European Medicines Agency · EMEA/H/C/002642 · revised March 4, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.